Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /
The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...
Saved in:
| 主要作者: | |
|---|---|
| 企业作者: | |
| 格式: | 电子 电子书 |
| 语言: | English |
| 出版: |
Heidelberg :
Physica-Verlag HD : Imprint: Physica,
2006.
|
| 版: | 1st ed. 2006. |
| 丛编: | Contributions to Management Science,
|
| 主题: | |
| 在线阅读: | https://doi.org/10.1007/3-7908-1668-X |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|